Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.
The post FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions appeared first on MedCity News.
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.
The post FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions appeared first on MedCity News.
Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems...
ByglobalreutersMarch 9, 2025Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes that...
ByglobalreutersMarch 7, 2025J&J said aticaprant showed insufficient efficacy in a Phase 3 test in...
ByglobalreutersMarch 7, 2025Can LLM experience anxiety? Impact of economic shocks on infant health. The...
ByglobalreutersMarch 7, 2025
Leave a comment